This titration strategy served several purposes: Reduced the severity of gastrointestinal side effects such as nausea, vomiting, and diarrhea Allowed clinicians to identify dose thresholds for tolerability versus efficacy Ensured progressive exposure to triple agonist activity without overwhelming the bodys hormonal systems Monitoring and Adjustments During escalation, patients were monitored for: Glucose control and insulin sensitivity Cardiovascular markers such as blood pressure and lipid profiles Liver enzymes and kidney function to assess safety at higher doses Adverse event reporting, especially GI events, which tend to peak during dose escalation This monitoring informed adjustments some participants remained at moderate doses if they were unable to tolerate higher weekly injections
Their team is here to answer your questions and help you find the right Healthier Tomorrows dietitian
The main published Phase 2 obesity study looked at retatrutide in adults with obesity, or overweight with at least one weight-related condition
PlexusDx medical team members review patient side effect reports at each appointment to identify patterns and adjust therapy proactively rather than reactively
In dual-agonist and triple-agonist research, it may contribute to a broader incretin response than GLP-1 alone
Dinner: 4 ounces baked salmon, medium sweet potato, 2 cups steamed broccoli or mixed green vegetables (400 calories, 30 grams protein) These are ranges for calorie counts and amounts of protein